Jake Gottlieb Altium

Posted on September 13, 2018 By

After running and managing different funds for about 20 years now, Stuart Weisbrod and Jacob Gottlieb have reunited under the same roof. The duo has ever worked together earlier at Merlin BioMed Group, and they are both great investors in healthcare. Therefore, the two have a full spectrum of knowledge about each other.

Presently, Jacob Gottlieb and Stuart Weisbrod are sharing offices and have, and it is predictable that they are set to sealing a collaboration in works in the future. Weisbrod was one of the founders of Merlin BioMed Group in the year 1998. The firm was created as an investment management firm and focused on a variety of healthcare portfolios such as Pharmaceutical, healthcare service sectors, medical device, and biotechnology.

Mr. Weisbrod earned himself a name through a successful track record in biotechnology and healthcare investment when he served in various positions in businesses such as Harpel Partners, Prudential-Bache Securities, Merrill Lynch, and Oracle Partners.

Weisbrod studied his BA in Chemistry at Colgate University and graduated in the year 1975. He later joined Columbia University attained an MBA in Finance in the year 1986. Stuart Weisbrod also studied his Ph.D. in Biochemistry at Princeton University where he graduated in 1980.

Weisbrod utilized his academic background to build a winning team around himself. In his team, Weisbrod appointed Jacob Gottlieb to work has his portfolio manager back in the year 2000. Moreover, Jacob Gottlieb was among the managers who helped Merlin to its height of the biotechnology revolution between 1999 and 2000. The team allowed the company to make more than 100% profit over that period.

Jacob Gottlieb and his fellow portfolio managers at Merlin became successful in helping the firm to generate large amounts of profit. In return, the managers landed on prominent customers including family offices, major pension funds, high net worth, and endowments individuals. Despite having a successful run, Merlin BioMed Group gave the money back to its investors. The company ended up closing its operations in the year 2007. After closing Merlin’s doors, Weisbrod has managed to successfully create another investment company known as Iguana Healthcare Partners that uses a similar investment strategy as that of Merlin.

Find out more about Jacob Gottlieb: http://inspirery.com/jacob-gottlieb/